Cardinal Strategic Wealth Guidance’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-193
Closed -$11.6K 64
2025
Q1
$11.6K Hold
193
﹤0.01% 58
2024
Q4
$11.3K Buy
+193
New +$11.5K ﹤0.01% 78
2023
Q1
Sell
-18
Closed -$946 89
2022
Q4
$946 Sell
18
-310
-95% -$15.7K ﹤0.01% 86
2022
Q3
$16K Sell
328
-35,113
-99% -$1.82M 0.01% 70
2022
Q2
$1.79M Buy
35,441
+9,138
+35% +$498K 0.91% 15
2022
Q1
$1.6M Buy
26,303
+6,139
+30% +$366K 0.74% 18
2021
Q4
$1.33M Buy
20,164
+2,372
+13% +$152K 0.62% 25
2021
Q3
$1.12M Sell
17,792
-29,584
-62% -$1.89M 0.59% 26
2021
Q2
$2.85M Buy
47,376
+534
+1% +$30.9K 1.5% 16
2021
Q1
$2.58M Buy
+46,842
New +$2.6M 1.51% 18

Other funds holding IHI

Cardinal Strategic Wealth Guidance's IHI Position: Q2 2025 in Review

Cardinal Strategic Wealth Guidance sold out of iShares US Medical Devices ETF (IHI) in Q2 2025, closing a stake of 193 shares — an estimated $11.6K sold.

Cardinal Strategic Wealth Guidance first reported a position in IHI in Q1 2021 and held it in 10 quarters. The position peaked at $2.85M in Q2 2021. 546 funds tracked by Wall St. Rank hold IHI as of Q2 2025.

  • Cardinal Strategic Wealth Guidance reported no remaining iShares US Medical Devices ETF position as of Q2 2025 after selling out during the quarter.
  • Cardinal Strategic Wealth Guidance sold 193 iShares US Medical Devices ETF shares in Q2 2025, an estimated $11.6K.
  • Cardinal Strategic Wealth Guidance first reported a position in iShares US Medical Devices ETF in Q1 2021 and held it in 10 quarters.
  • Cardinal Strategic Wealth Guidance's iShares US Medical Devices ETF position peaked at $2.85M in Q2 2021.
  • 546 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2025.

Based on Cardinal Strategic Wealth Guidance's 13F filing for Q2 2025, filed 21 Jul 2025.